European life sciences investor Medicxi has bundled together six privately-held companies with dermatology medicines in development under a single drugmaker – called Alys
A trip to the annual Medica trade fair in Dusseldorf is a must for people like me, looking to keep on top of what’s happening globally in the field of biotech, medical technology, and pharm
A thriving start-up ecosystem is essential to the health of the modern life sciences industry, as it provides an incubator for innovative ideas that might be too high-risk for larger, more
The global boom in start-up valuations has abruptly stopped. How can biotech start-ups buck this trend and create sustainable, valuable businesses over the long-term?
The FDA has approved Akebia Therapeutics’ vadadustat as a treatment for anaemia caused by chronic kidney disease (CKD) in dialysis patients, becoming the first rival to GS